Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

2 passages

referencesuptodate· REFERENCES· item f12_46_13031

REFERENCES Allen RM, “Palliative Treatment of Tardive Dyskinesia With Combination of Amantadine-Neuroleptic Administration,” Biol Psychiatry , 1982, 17(6):719-27. [PubMed 6179548 ] Alphs L and Davis JM, “Noncatecholaminergic Treatments of Tardive Dyskinesia,” J Clin Psychopharmacol , 1982, 2(6):380-5. [PubMed 6129267 ] Aoki FY and Sitar DS, “Amantadine Kinetics in Healthy Elderly Men: Implications for Influenza Prevention,” Clin Pharmacol Ther , 1985, 37(2):137-44. [PubMed 3967456 ] Aoki FY and Sitar DS, “Clinical Pharmacokinetics of Amantadine Hydrochloride,” Clin Pharmacokinet , 1988, 14(1):35-51. [PubMed 3280212 ] Borison RL, “Amantadine in the Management of Extrapyramidal Side Effects,” Clin Neuropharmacol , 1983, 6(Suppl 1):57-63. Bradley JS, Byington CL, Shah SS, et al. “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, Clin Infect Dis , 2011, 53(7):e25-76. [PubMed 21880587 ] Centers for Disease Control and Prevention (CDC), "Influenza Division, National Center for Immunization and Respiratory Diseases. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza --- Recommendations of the Advisory Committee on Immunization Practices (ACIP)," MMWR Surveill Summ , 2011, 60(1):1-28. [PubMed 21248682 ] Centers for Disease Control and Prevention, "Interim Guidance: Considerations Regarding 2009 Novel H1N1 Flu Virus in Intrapartum and Postpartum Hospital Settings," Available at file://www.cdc.gov/h1n1flu/guidance/obstetric.htm [PubMed 12755288 ] “Drugs for Non-HIV Viral Infections,” Med Lett Drugs Ther , 2002, 44(1123):9-16. [PubMed 11828264 ] Factor SA, “Current Status of Symptomatic Medical Therapy in Parkinson’s Disease,” Neurotherapeutics , 2008, 5(2):164-80. [PubMed 18394561 ] Koller WC, Silver DE, and Lieberman A, “An Algorithm for the Management of Parkinson's Disease,” Neurology , 1994, 44(12 Suppl 10):1-52. [PubMed 8290041 ] Merigan KS, and Browning RG, “Despiramine and Amantadine Causing False-Positive Urine Test for Amphetamine,” Ann Emerg Med , 1993, 22(12):1927-28. [PubMed 8239121 ] Miller KS and Miller JM, “Toxic Effects of Amantadine in Patients With Renal Failure,” Chest , 1994, 105(5):1630.

referencesuptodate· REFERENCES· item f12_46_13031

Koller WC, Silver DE, and Lieberman A, “An Algorithm for the Management of Parkinson's Disease,” Neurology , 1994, 44(12 Suppl 10):1-52. [PubMed 8290041 ] Merigan KS, and Browning RG, “Despiramine and Amantadine Causing False-Positive Urine Test for Amphetamine,” Ann Emerg Med , 1993, 22(12):1927-28. [PubMed 8239121 ] Miller KS and Miller JM, “Toxic Effects of Amantadine in Patients With Renal Failure,” Chest , 1994, 105(5):1630. Molina JA, Sàinz-Artiga MJ, Fraile A, et al, “Pathologic Gambling in Parkinson's Disease: A Behavioral Manifestation of Pharmacologic Treatment,” Mov Disord , 2000, 15(5):869-72. [PubMed 11009192 ] Poldinger W, “Therapy of Extrapyramidal Side Effects, With Particular Reference to Persistent Dyskinesia and Lithium Tremor,” International Pharmacopsychiatry , 1978, 13(4):230-3. [PubMed 32149 ] Somani SK, Degelau J, Cooper SL, et al, “Comparison of Pharmacokinetic and Safety Profiles of Amantadine 50- and 100-mg Daily Doses in Elderly Nursing Home Residents,” Pharmacotherapy , 1991, 11(6):460-6. [PubMed 1771145 ] Stange KC, Little DW, and Blatnik B, “Adverse Reactions to Amantadine Prophylaxis of Influenza in a Retirement Home,” J Am Geriatr Soc , 1991, 33(7):700-5. Strong DK, Eisenstat DD, Bryson SM, et al, “Amantadine Neurotoxicity in a Pediatric Patient With Renal Insufficiency,” DICP , 1991, 25(11):1175-7. [PubMed 1763530 ] Weintraub D, Siderowf AD, Potenza MN, et al, “Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease,” Arch Neurol , 2006, 63(7):969-73. [PubMed 16831966 ] Zubenko GS, Barreira P, and Lipinski JF Jr, “Development of Tolerance to the Therapeutic Effect of Amantadine on Akathisia,” J Clin Psychopharmacol , 1984, 4(4):218-20. [PubMed 6470196 ] Topic 8508 Version 41.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [1004-85.214.214.87-89768E4622-S473950.14]